Loading...
Pasireotide Diaspartate
Pasireotide Diaspartate

Pasireotide Diaspartate

Catalog No. KMP049001
CAS No. 1421446-02-7
Formula C58H66N10O9 : 2(C4H7NO4)
FW 1047.2 : 2(133.1)
Unit Price Stock
100 mg Enquire Enquire
Chemical Name: (3S,6R,9S,12S,15S,19R,20aS)-6-((1H-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamate bis(L-aspartate)
Purity: >95%
Storage: Store at 2-8 deg. C for long term storage
Shipping: Product is stable to be Shipped at Room Temperature
Pasireotide Diaspartate is chemically (3S,6R,9S,12S,15S,19R,20aS)-6-((1H-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamate bis(L-aspartate) . Pasireotide Diaspartate is supplied with detailed characterization data compliant with regulatory guideline. Pasireotide Diaspartate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pasireotide Diaspartate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.

Related Products

CAT No: KMP049002
Pasireotide Impurity 1

CAS No.: NA

CAT No.: KMP049002

Formula : C57H66N10O10

FW : 1051.2

CAT No: KMP049003
Pasireotide Impurity 2

CAS No.: 741701-25-7

CAT No.: KMP049003

Formula : C58H66N10O9

FW : 1047.2

CAT No: KMP049004
Pasireotide Impurity 3

CAS No.: NA

CAT No.: KMP049004

Formula : C55H60N8O8

FW : 961.1

CAT No: KMP049005
Pasireotide Impurity 4

CAS No.: NA

CAT No.: KMP049005

Formula : C58H66N10O9

FW : 1047.2

CAT No: KMP049006
Pasireotide Impurity 5

CAS No.: NA

CAT No.: KMP049006

Formula : C60H68N10O9

FW : 1073.3